Harvard Bioscience, Inc. stock is up 27.32% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 78.26% of the previous 23 December’s closed higher than November.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.